These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38733347)

  • 1. Alzheimer's disease: insights into pathology, molecular mechanisms, and therapy.
    Zheng Q; Wang X
    Protein Cell; 2024 May; ():. PubMed ID: 38733347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease.
    Kashif M; Sivaprakasam P; Vijendra P; Waseem M; Pandurangan AK
    Curr Pharm Des; 2023; 29(43):3428-3441. PubMed ID: 38038007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifestyle Modifications and Nutritional Interventions in Aging-Associated Cognitive Decline and Alzheimer's Disease.
    Bhatti GK; Reddy AP; Reddy PH; Bhatti JS
    Front Aging Neurosci; 2019; 11():369. PubMed ID: 31998117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the Pathophysiology of Alzheimer's Disease and Potential Therapeutic Targets: A Current Perspective.
    Rajah Kumaran K; Yunusa S; Perimal E; Wahab H; Müller CP; Hassan Z
    J Alzheimers Dis; 2023; 91(2):507-530. PubMed ID: 36502321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on Alzheimer's Disease Therapy and Prevention Strategies.
    Graham WV; Bonito-Oliva A; Sakmar TP
    Annu Rev Med; 2017 Jan; 68():413-430. PubMed ID: 28099083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
    Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Contribution of Cerebral Vascular Neuropathology to Mild Stage of Alzheimer's Dementia Using the NACC Database.
    Liu Y; Chan DK; Crawford JD; Sachdev PS; Braidy N
    Curr Alzheimer Res; 2020; 17(13):1167-1176. PubMed ID: 33583381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothesis review: Alzheimer's overture guidelines.
    Ferrer I
    Brain Pathol; 2023 Jan; 33(1):e13122. PubMed ID: 36223647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron and Alzheimer's Disease: From Pathology to Imaging.
    Tran D; DiGiacomo P; Born DE; Georgiadis M; Zeineh M
    Front Hum Neurosci; 2022; 16():838692. PubMed ID: 35911597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease.
    Cohen AD; Landau SM; Snitz BE; Klunk WE; Blennow K; Zetterberg H
    Mol Cell Neurosci; 2019 Jun; 97():3-17. PubMed ID: 30537535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental toxins and Alzheimer's disease progression.
    Vasefi M; Ghaboolian-Zare E; Abedelwahab H; Osu A
    Neurochem Int; 2020 Dec; 141():104852. PubMed ID: 33010393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of dementia.
    Chin KS
    Aust J Gen Pract; 2023 Aug; 52(8):516-521. PubMed ID: 37532448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking Cerebrovascular Dysfunction to Age-Related Hearing Loss and Alzheimer's Disease-Are Systemic Approaches for Diagnosis and Therapy Required?
    Förster CY; Shityakov S; Scheper V; Lenarz T
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosenescence and Aging: Neuroinflammation Is a Prominent Feature of Alzheimer's Disease and Is a Likely Contributor to Neurodegenerative Disease Pathogenesis.
    Bowirrat A
    J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From understanding to action: Exploring molecular connections of Down syndrome to Alzheimer's disease for targeted therapeutic approach.
    Sukreet S; Rafii MS; Rissman RA
    Alzheimers Dement (Amst); 2024; 16(2):e12580. PubMed ID: 38623383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Novel microRNAs in Developing Novel Alzheimer's Disease Treatments.
    Seyedaghamiri F; Rajabi M; Mohaddes G
    Neurochem Res; 2023 Jan; 48(1):26-38. PubMed ID: 36048350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent update on the heterogeneity of the Alzheimer's disease spectrum.
    Jellinger KA
    J Neural Transm (Vienna); 2022 Jan; 129(1):1-24. PubMed ID: 34919190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Vascular-Immune Hypothesis of Alzheimer's Disease.
    Mehta RI; Mehta RI
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.